Want to see SEED full AI Analyst Report?
Top Page
Origin Agritech
(NASDAQ:SEED)
Select Model
Select Model
Rating:45Neutral
Price Target:
$0.98
▼(-26.14% Downside)
Action:Reiterated
Date:05/22/26
The score is held down primarily by weak financial performance (volatile results, cash burn, and negative equity with higher debt) and a bearish technical setup (below key moving averages with negative MACD). The earnings call provides some offset from improving loss trends and concrete operational milestones, but revenue decline, liquidity/liability pressures, and execution/regulatory dependency keep the overall profile risk-heavy.
Positive Factors
Biotech credentials & commercial readiness
Holding a biosafety certificate, production licenses and a restored processing facility materially reduces operational barriers to commercial GMO seed sales and enables near-term scaling. The Marker Consortium creates a pathway to monetize biotech IP beyond direct seed sales, strengthening long-term commercialization options and partnerships.
Negative Factors
Stressed balance sheet
Negative equity and a meaningful increase in debt materially reduce financial flexibility and raise refinancing and dilution risk. A contracted asset base since 2023 limits collateral and borrowing capacity, constraining the company’s ability to fund multi-year commercial rollouts and absorb execution delays without external capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Biotech credentials & commercial readiness
Holding a biosafety certificate, production licenses and a restored processing facility materially reduces operational barriers to commercial GMO seed sales and enables near-term scaling. The Marker Consortium creates a pathway to monetize biotech IP beyond direct seed sales, strengthening long-term commercialization options and partnerships.
Read all positive factors
Origin Agritech (SEED) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$12.26M
Dividend YieldN/A
Average Volume (3M)2.25M
Price to Earnings (P/E)―
Beta (1Y)0.62
Revenue Growth-25.50%
EPS Growth-905.27%
CountryUS
Employees97
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)-4.40
Shares Outstanding12,143,526
10 Day Avg. Volume6,011,928
30 Day Avg. Volume2,246,586
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-2.76
Price to Sales (P/S)0.71
P/FCF Ratio-1.80
Enterprise Value/Market Cap6.75
Enterprise Value/Revenue2.41
Enterprise Value/Gross Profit25.06
Enterprise Value/Ebitda-7.18
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Origin Agritech Business Overview & Revenue Model
Company Description
Established in 1997 and headquartered in Beijing, China, Origin Agritech Limited is a Chinese firm operating in two primary areas: agricultural biotechnology and an e-commerce platform. Its biotechnology segment focuses on the genetic enhancement ...
How the Company Makes Money
Origin Agritech primarily makes money by commercializing crop seed products it develops or controls, generating revenue through the sale and distribution of seeds (including hybrid and biotech-enhanced varieties) to farmers and agricultural channe...
Origin Agritech Earnings Call Summary
Earnings Call Date:May 21, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Jan 11, 2027
Earnings Call Sentiment Neutral
The call presented a balanced view: clear operational and structural progress (large cuts in G&A, improved operating loss, strengthened biotech credentials, rebuilt sales force, sizable breeding pipeline and targeted variety acquisitions) alongside meaningful near-term challenges (a 31.9% revenue decline, ongoing net loss, modest cash position, higher inventories and dependency on regulatory timing for GMO commercialization). Management emphasized that the company is in the midpoint of a recovery plan and investing in sales and R&D to convert pipeline into revenue, but realization of that upside remains contingent on execution and policy developments.Positive Updates
Strategic Restructuring Showing Early Financial Impact
Total operating expenses fell to RMB 18.4M in H1 FY2026 from RMB 32.8M prior year, a 43.9% reduction, driven by a 69.8% decline in general and administrative expenses (RMB 25.0M to RMB 7.6M). Loss from operations improved to RMB 12.9M vs RMB 24.7M prior year (47.8% reduction) and net loss attributable improved to RMB 14.4M from RMB 25.6M (43.8% improvement).
Negative Updates
Significant Revenue Decline
Total revenues for H1 FY2026 were RMB 49.2M (USD 7.1M) vs RMB 72.3M prior year, a decrease of approximately 31.9%, driven primarily by a strategic shift from external seed tolling services toward new corn seed product sales.
Read all updates
Q2-2026 Updates
Positive
Negative
Strategic Restructuring Showing Early Financial Impact
Total operating expenses fell to RMB 18.4M in H1 FY2026 from RMB 32.8M prior year, a 43.9% reduction, driven by a 69.8% decline in general and administrative expenses (RMB 25.0M to RMB 7.6M). Loss from operations improved to RMB 12.9M vs RMB 24.7M prior year (47.8% reduction) and net loss attributable improved to RMB 14.4M from RMB 25.6M (43.8% improvement).
Read all positive updates
Company Guidance
The explicit guidance from management was that operating leverage is becoming visible and the company expects the rebuilt foundation to convert into commercial outcomes by the first half of fiscal 2027, with a longer‑term goal of becoming a top‑3 Chinese corn seed company by 2030–2032; near‑term execution metrics cited include a 36‑person sales force deployed against KPI contracts with six regional sales companies under the Aoyun 2026 program, spring planting field activity underway, and commercialization readiness with a BBL2‑2 biosafety certificate, two crop seed production licenses and a restored Xinjiang processing facility. Financially, management is prioritizing intentional investment in selling and marketing (S&M up 93.3% to RMB 5.1m) and steady R&D (up 11.1% to RMB 5.7m) while driving cost discipline (total OPEX down 43.9% to RMB 18.4m, G&A down 69.8% to RMB 7.6m), with revenues of RMB 49.2m (‑31.9% YoY), gross profit RMB 5.5m, operating loss narrowing to RMB 12.9m (‑47.8% YoY) and net loss improving to RMB 14.4m (‑43.8%), cash RMB 13.4m, inventories RMB 24.8m, short‑term borrowings RMB 9.5m and total liabilities RMB 168.1m; R&D pipeline metrics highlighted include >30,000 winter test‑cross combinations, >10,000 new combinations added to the test pipeline, Hi3 platform use and AI models leveraging >200,000 germplasm resources.Origin Agritech Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
18
Very Negative
Cash Flow
22
Negative
| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.28M | 91.29M | 113.38M | 93.31M | 52.58M | 46.42M |
| Gross Profit | 3.30M | 6.39M | 16.07M | 17.25M | 16.19M | 12.81M |
| EBITDA | -11.52M | -52.31M | 23.08M | 67.84M | -8.99M | -59.77M |
| Net Income | -13.10M | -53.33M | 20.71M | 55.33M | -6.26M | -91.53M |
Balance Sheet | ||||||
| Total Assets | 92.57M | 100.65M | 131.56M | 238.51M | 135.96M | 119.04M |
| Cash, Cash Equivalents and Short-Term Investments | 13.37M | 15.88M | 8.38M | 23.71M | 17.67M | 15.35M |
| Total Debt | 29.12M | 26.13M | 5.08M | 241.00K | 139.28M | 140.77M |
| Total Liabilities | 168.09M | 162.16M | 190.16M | 319.77M | 308.60M | 304.64M |
| Stockholders Equity | -37.66M | -23.34M | -31.29M | -57.40M | -133.87M | -140.67M |
Cash Flow | ||||||
| Free Cash Flow | -23.42M | -35.92M | -20.00M | -17.66M | 2.67M | -26.79M |
| Operating Cash Flow | -12.85M | -22.57M | -15.03M | -5.46M | 3.29M | -25.08M |
| Investing Cash Flow | -11.49M | -14.28M | -4.97M | -11.22M | -1.10M | -1.21M |
| Financing Cash Flow | 35.02M | 44.47M | 4.50M | 22.93M | -332.00K | 19.84M |
Origin Agritech Technical Analysis
Negative
1.32
Price Trends
1.07
Negative
1.14
Negative
1.26
Negative
Market Momentum
-0.01
Negative
46.17
Neutral
27.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SEED, the sentiment is Negative. The current price of 1.32 is above the 20-day moving average (MA) of 1.02, above the 50-day MA of 1.07, and above the 200-day MA of 1.26, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 46.17 is Neutral, neither overbought nor oversold. The STOCH value of 27.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SEED.
Origin Agritech Risk Analysis
Origin Agritech disclosed 53 risk factors in its most recent earnings report. Origin Agritech reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Origin Agritech Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | $76.66M | -1.69 | -21.86% | ― | -0.96% | 66.81% | |
47 Neutral | $63.02M | -4.47 | -88.01% | ― | 26.90% | -18.62% | |
45 Neutral | $12.26M | -1.11 | ― | ― | -25.50% | -905.27% | |
43 Neutral | $21.70M | -0.09 | -149.05% | ― | -31.20% | -796.06% | |
42 Neutral | $1.49M | -0.09 | -80.74% | ― | -9.53% | -286.64% |
* Basic Materials Sector Average
SEED
Origin Agritech
1.02
0.11
11.65%
AVD
American Vanguard
2.66
-1.12
-29.63%
RKDA
Arcadia Biosciences
0.62
-4.13
-86.86%
BHST
BioHarvest Sciences
2.77
-4.28
-60.71%
BIOX
Bioceres Crop Solutions
0.34
-3.70
-91.56%
Origin Agritech Corporate Events
Origin Agritech Narrows Loss but Sees Revenue Drop on Shift to New Corn Seeds
May 21, 2026
Origin Agritech reported unaudited results for the first half of fiscal 2026 ended March 31, 2026, showing net revenue of RMB49.2 million, down from RMB72.3 million a year earlier as it reduced lower-margin seed tolling in favor of new corn seed p...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.